Announcements

Sativa Group Plc's CEO Henry Lees-Buckley sets out his ambitions for the business
Proactive London sits down with the newly appointed CEO of Sativa Group PLC (LON:SATI) Henry Lees-Buckley. Lees-Buckley is a former global executive at Fortune 500 industrial supply firm W. W. Grainger (NYSE:GWW) and joins the group…
Exercise of Options (3 September 2019)
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Sativa completes initial phase of Goodbody CBD Wellness store chain, opening its third store and advancing to franchise roll-out
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Sativa appoints Henry Lees-Buckley CEO as business develops
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
INTERVIEW: Sativa Group ‘A Big Boost’ from Health Secretary’s Statement
Sativa Group (NEX: SATI) CEO Geremy Thomas joins DirectorsTalk to comment on the statement made by Health Secretary Matt Hancock. Geremy also explains the significance of appointing new broker Cenkos. Sativa is a seed to Consumer…
INTERVIEW: Sativa delighted with Cenkos appointment as it opens CBD wellness centre
Geremy Thomas caught up with Proactive London’s Andrew Scott following the opening of their first cannabidiol (CBD) wellness retail outlet in Bath at the weekend. (Published on 3 Jul 2019) The Goodbody Wellness store was launched…
Sativa Group PLC UK's first prestige CBD wellness chain launched
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Phytovista subsidiary completes largest UK CBD industry blind product test for The Centre for Medicinal Cannabis.
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Exercise of Warrants and Options
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Appointment of Cenkos Securities plc as Corporate Adviser and broker
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Result of Annual General Meeting and Trading Update
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announce Result of Annual General Meeting and Trading Update
Offtake agreement with Swiss supplier of cannabis oil for the UK manufacture of cannabidiol (CBD) products
Press Release 15th May 2019  The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the…
Offtake agreement with Portuguese supplier of cannabis oil for the UK manufacture of cannabidiol products
Press Release                                                                    …
INTERVIEW: Geremy Thomas, CEO of Sativa Investments shares his views on the European cannabis market... (as featured on Professionally Cannabis)
Professionally Cannabis, met up with Geremy Thomas, CEO of Sativa Investments; Among many topics, they spoke about the companies that sit within the Sativa Group, Geremy’s views on the European cannabis market, and exciting new developments…
Final Results
Press Release                                                                    …
Exercise of Share Options and Total Voting Rights
Press Release                                                                    …
Sativa Strategic Update - 8th May 2019
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa to open first Goodbody & Blunt wellness centre in Bath with lease signed
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa begins cannabinoid research with King’s College London
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London (“the College”) to research the impact of cannabinoids on inflammation and respiratory diseases.
Sativa’s PhytoVista Laboratories’ 1000th cannabinoid and terpenes test and two new hires
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Appointment of Director of Regulatory affairs
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Sativa hires retail expert Chris Jones to launch Sativa’s Goodbody & Blunt wellness centres
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Sativa Investments 'at the forefront' of developing UK medical cannabis market
Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London’s Andrew Scott to discuss the NEX-based medical cannabis investor’s trading and strategic update.
Strategic and Trading Update
Press Release 8th January 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the…
Investee business Rapid Dose Therapeutics lists on the Canadian Securities Exchange
Press Release 18 December 2018 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via…
Dr Brown appointed to Advisory Board
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this…
Share Option Scheme
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that the Company has adopted the Sativa Investments PLC Share Plan (the “Scheme”), to recognise the work accomplished by the Sativa team
Option agreement on 298,806 sq ft glasshouse signed
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has now signed the option agreement to lease a 7.53 acre site for medicinal cannabis production in Wiltshire on which the Company intends to…
Change in Board responsibilities
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, announces that Mark Blower, currently an Executive Director of the Company, is moving to a non-Executive Director role with immediate effect.
Medicinal cannabis group Sativa enters joint venture with Lexamed GmbH
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has established a joint venture with German-based Lexamed GmbH (“Lexamed”), forming a new German medicinal cannabis company named Sativa Germany GmbH
Sativa appoints Chief Financial Officer and Director
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has appointed Joseph Colliver FCA as Chief Financial Officer and a Director of the Company.
Directors’ appointments/resignation
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has appointed Jonathan Peter Wearing as an independent non-executive director and Angus Jeremy Kerr as a non-executive director of the Company.
Sativa signs IP agreement with Canadian-based Veritas Pharma Inc.
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has signed an IP sharing agreement with Canadian-based emerging global pharmaceutical company Veritas Pharma Inc. (“Veritas” or “Veritas Pharma”) in which the Company invested…
Sativa agrees to the 100% purchase of PhytoVista Laboratories
Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has agreed to purchase, for £435,000, 100 per cent of PhytoVista Laboratories (“PhytoVista”), a UK-based laboratory that tests CBD oils and hemp products.
Dealing Arrangements
The Board of Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is aware of the exceptional and growing demand amongst investors to own shares in the Company. As announced on the Company’s…
Share Placing completed to Miton Asset Management
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that the share Placing of 12,500,000 new Ordinary Shares at a subscription price of 4 pence per share announced on Wednesday 27 June, raising…
Sativa Share Placing
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that it has raised £500,000 before expenses by way of a placing of 12,500,000 new Ordinary Shares at 4 pence per share to a…
Orderly Market Agreement - Director’s Dealing
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that today, 25 June 2018, Mark Blower, an executive director of the Company, sold 1,000,000 ordinary shares of £0.0025 at a price of £0.04…
Sativa Foundation to fund academic research in to medicinal cannabis
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has formed the Sativa Foundation (“The Foundation”) to fund academic research into medicinal cannabis and its benefits to the pharmaceutical and healthcare sectors.
Sativa agrees purchase of 100% of CBD product provider George Botanicals
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has agreed to purchase, for £415,000, 100 per cent of George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor of wellness CBD products, following the…
Sativa passes resolution at General Meeting to broaden investment policy
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, announces that all Resolutions were passed by the requisite majority at the Company’s General Meeting today, including Resolutions to broaden its investment strategy beyond Canada,…
Sativa Share Price Movement
The Board of Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, notes the recent rise in the Company’s share price. Whilst the Company has made investments to date, it is unaware of any…
Sativa appoints pharmacologist Sir Alasdair Breckenridge to its Advisory Board
Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has appointed Sir Alasdair Breckenridge to its Advisory Board, whose medical career as a pharmacologist totals close to 60 years.
SATI Sativa Investments PLC broadens investment strategy
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, is seeking shareholder approval to broaden its investment policy beyond Canada and has today notified shareholders of a General Meeting to be held on 22…
Sativa invests C$ 0.2 million in Canadian-based Rapid Dose Therapeutics Inc
Sativa Investments PLC has subscribed to, through a private placement which may or may not precede an IPO, 400,000 shares at C$ 0.50 per share, at a cost of C$ 0.2 million cash, in Toronto-based Pharma-Tech…
Sativa Investments commits to C$ 0.2 million investment in Canadian-based Veritas Pharma
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, has subscribed for 500,000 new shares at C$ 0.40 per share, at a cost of C$ 0.2 million cash, in Canadian-based emerging global pharmaceutical company…
Orderly Market Agreement - Director's Dealing
Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that, on 16 April 2018, Noel Lyons, a non-executive director of the Company, sold 750,000 ordinary shares of £0.0025 each in the Company at…
Sativa Investments PLC MOU with George Botanicals
Press Release        Tuesday 17th April 2018 Sativa Investments PLC (“Sativa” or “the Company”) Sativa signs Memorandum of Understanding to purchase 51% of CBD product provider George Botanicals Sativa Investments PLC [NEX:SATI], the UK’s…
SATI FDD Admission to NEX Exchange Growth Market Release
Press Release        Thursday 29th March 2018 Sativa Investments PLC (“Sativa” or “the Company”) Admission to NEX Exchange Growth Market having raised £1.1 million    Sativa Investments PLC, the UK’s first medicinal cannabis Investment…